Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Lee P. Shulman, MD, FACMG, FACOG
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
Linda Bradley, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
Melissa Simon, MD
Samantha Denäe
Casey Joe Hinds
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Clinical Considerations for the Diagnosis of Endometriosis
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
Pre- and Postoperative Use of GnRH Antagonists
Creating a Practice Environment That Enhances Healthcare Equality for All Patients
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
The Impact of Early Diagnosis in Improving Patient Outcomes in Endometriosis: Physical and Psychosocial Consequences
Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Patient-Centric Tools to Support Shared Decision-Making: Diagnosing and Assessing Endometriosis
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.